Bisacodyl

比沙可啶

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameBisacodyl
Drug Alias Name双醋苯啶bisacodyl比沙可淀bisacodilobisacodylum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPharmaceutical aidsAutism Spectrum DisorderEncopresis +[4] 
Global Approved IndicationsConstipation
Approved Indications in ChinaConstipation
Original Approved Country/TerritoryN/A
Original Approved Date1953/01/01
Country/TerritoryCanadaUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanofiPfizer IncAventis Pharmaceuticals Inc +[5] 
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgEuropean Institute Of OncologyLawson Health Research Institute
Active IndicationsAutism Spectrum DisorderEncopresisConstipation
Inactive IndicationsPharmaceutical aids

Other Information

ATC CodeA06AB02A06AG02
Related LinksWikipediaDrugBankKEGG